Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€58.92

€58.92

-1.730%
-1.04
-1.730%
€63.50

€63.50

 
Latest predictions
€90.00
17.02.21
buy
€59.00
24.11.20
buy
-
28.10.20
€35.00
17.03.20
buy
€67.00
03.02.20
buy
€60.00
23.04.19
buy
Your prediction

Dermapharm Holding SE Stock

We can see a decrease in the price for Dermapharm Holding SE. Compared to yesterday it has lost -€1.040 (-1.730%).
Currently there is a rather positive sentiment for Dermapharm Holding SE with 5 Buy predictions and 1 Sell predictions.
With a target price of €63.00 there is a slightly positive potential of 6.925% for Dermapharm Holding SE compared to the current price of €58.92.

Pros and Cons of Dermapharm Holding SE in the next few years

Pros
?
Brand
?
Shareholder structure
?
Market Position
Cons
?
Conscious of the environment
?
Growth compared to competition
?
Worthwhile Investment for the next years
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Dermapharm Holding SE vs. its peers

Security Change (%) 1w 1m 1y YTD 3y 5y
Dermapharm Holding SE -1.730% -1.544% -4.355% 50.200% 4.387% - -
Emerita Resources 1.670% 0.549% 40.769% 297.826% 27.972% - -

Other discussions about Dermapharm Holding SE Stock

New thread Forum

News

DGAP-News: Dermapharm Holding SE continues on its growth course in third quarter of 2020
DGAP-News: Dermapharm Holding SE continues on its growth course in third quarter of 2020
DGAP-News: Dermapharm Holding SE - subsidiary axicorp GmbH breaks ground for a new building near Frankfurt/Main
DGAP-News: Dermapharm Holding SE - subsidiary axicorp GmbH breaks ground for a new building near Frankfurt/Main
DGAP-News: Dermapharm Holding SE signs cooperation and delivery agreement with BioNTech SE on the production of a COVID-19 vaccine
DGAP-News: Dermapharm Holding SE signs cooperation and delivery agreement with BioNTech SE on the production of a COVID-19 vaccine